Target intelligence / Profile preview

Retinoic acid-inducible gene I receptor (RIG-I)

Target
RIG-I
Molecular classification
Pattern Recognition Receptor, DExD/H-box RNA helicase
01

Overview

RIG-I is a cytosolic pattern recognition receptor (PRR) that plays a critical role in the innate immune system by detecting viral RNA within cells. It is essential for initiating antiviral responses, particularly through the induction of type I interferons (IFN-α/β), which help limit viral spread and activate both innate and adaptive immunity. It recognizes short double-stranded RNAs (dsRNA) or single-stranded RNAs with blunt ends bearing a 5′ triphosphate or diphosphate group. Upon binding its ligand, RIG-I undergoes conformational change exposing CARDs, which interact with mitochondrial antiviral signaling protein (MAVS), triggering downstream signaling pathways.

02

Mechanism of action

Activation of MAVS-dependent signaling pathways, leading to transcription of type I interferons and pro-inflammatory cytokines.

03

Biological functions

Innate immune responseAntiviral signalingType I interferon inductionInflammatory responseViral RNA recognition
04

Disease associations

InfectionAutoimmunityInflammationCancer (potential)
05

Safety considerations

Potential for excessive inflammationOff-target effects on host RNARisk of autoimmunity with prolonged activation
06

Interacting drugs

Poly(I:C)

2 more in the full profile.

Beyond the preview

Go deeper on Retinoic acid-inducible gene I receptor (RIG-I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoic acid-inducible gene I receptor (RIG-I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call